During the last session, Adicet Bio Inc (NASDAQ:ACET)’s traded shares were 1.04 million, with the beta value of the company hitting 1.67. At the end of the trading day, the stock’s price was $0.65, reflecting an intraday loss of -6.70% or -$0.05. The 52-week high for the ACET share is $1.70, that puts it down -161.54 from that peak though still a striking 30.77% gain since the share price plummeted to a 52-week low of $0.45. The company’s market capitalization is $54.01M, and the average trade volume was 520.19K shares over the past three months.
Adicet Bio Inc (ACET) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.57. ACET has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.28.
Adicet Bio Inc (NASDAQ:ACET) trade information
Adicet Bio Inc (ACET) registered a -6.70% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -6.70% in intraday trading to $0.65, hitting a weekly high. The stock’s 5-day price performance is -12.86%, and it has moved by 5.34% in 30 days. Based on these gigs, the overall price performance for the year is -57.32%.
The consensus price target of analysts on Wall Street is $32.5, which implies an increase of 98.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $27 and $38 respectively. As a result, ACET is trading at a discount of -5746.15% off the target high and -4053.85% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 36.74%. While earnings are projected to return 18.90% in 2025, the next five years will return 20.90% per annum.
ACET Dividends
Adicet Bio Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Adicet Bio Inc (NASDAQ:ACET)’s Major holders
The next largest institutional holding, with 8.22 million shares, is of TANG CAPITAL MANAGEMENT LLC’s that is approximately 9.0663% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $9.94 million.
Also, the Mutual Funds coming in first place with the largest holdings of Adicet Bio Inc (ACET) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 2.07 shares. This amounts to just over 2.51 percent of the company’s overall shares, with a $1.35 million market value. The same data shows that the other fund manager holds slightly less at 1.08, or about 1.31% of the stock, which is worth about $0.7 million.
